Introduction: animal models of immunotherapy of cancer
Rapp, H.J.
National Cancer Institute Monograph 39: 1-2
1973
ISSN/ISBN: 0083-1921 PMID: 4595318 Document Number: 68372
Document emailed within 1 workday
Related Documents
Consroe, P.; Edmonds, H.L. 1979: Genetic animal models of epilepsy. Introduction Federation Proceedings 38(10): 2397-2398Prosser, C.L. 1973: Animal models for biomedical research. V. Invertebrates. Introduction Federation Proceedings 32(12): 2177-2178
Rapp, H.J. 1979: Appropriateness of animal models for the immunology of human cancer Cancer Research 39(10): 4285-4287
Bosland, M.C. 1999: Use of animal models in defining efficacy of chemoprevention agents against prostate cancer European Urology 35(5-6): 459-463
Mathé, G.; Halle-Pannenko, O.; Bourut, C. 1973: BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy National Cancer Institute Monograph 39(8): 107-113
Mashiba, T.; Iwata, K.; Komatsubara, S.; Manabe, T. 2011: Animal models for bone and joint disease. Animal fracture model and fracture healing process Clinical Calcium 21(2): 235-241
Parmiani, G. 1994: Immunotherapy of tumors. Introduction Immunology Series 61: 227-230
Klein, E. 1979: Introduction--immunological reactions and immunotherapy of malignant disease Advances in Experimental Medicine and Biology 114: 717-725
Stevenson, F.; Anderson, K.C. 1999: Introduction: immunotherapy for multiple myeloma--insights and advances Seminars in Hematology 36(1 Suppl. 3): 1-2
Pantazis, P.; Han, Z.; Balan, K.; Wang, Y.; Wyche, J.H. 2003: Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models Anticancer Research 23(5a): 3623-3638
Nagasawa, R.; Maruyama, N. 1988: Study of autoimmune diseases using animal disease models. 1) Molecular genetic analysis of autoimmune disease models Nihon Rinsho. Japanese Journal of Clinical Medicine 46(4): 845-849
Dowling, J.E. 1977: Research models for retinitis pigmentosa: introduction Advances in Experimental Medicine and Biology 77: 85-86
Date, M.; Otsu, K.; Kuzuya, T.; Hori, M. 2000: Animal models of cardiomyopathy Nihon Rinsho. Japanese Journal of Clinical Medicine 58(1): 233-239
Hau, T.; Simmons, R.L. 1977: Animal models of peritonitis Surgery Gynecology and Obstetrics 144(5): 755-756
Meyer, O. 1981: Animal models in lupus Revue du Rhumatisme et des Maladies Osteo-Articulaires 48(12): 817-825
Kusewitt, D.F.; Ley, R.D. 1996: Animal models of melanoma Cancer Surveys 26: 35-70
Ursick, J.; Staecker, H. 2007: An overview of animal models of tinnitus B-Ent 3(Suppl 7): 23-25
Bhatnagar, A.; Majumdar, S. 2003: Animal models of hepatic encephalopathy Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 22(Suppl 2): S33-S36
Tincani, A.; Spatola, L.; Cinquini, M.; Meroni, P.; Balestrieri, G.; Shoenfeld, Y. 1998: Animal models of antiphospholipid syndrome Revue du Rhumatisme 65(11): 614-618
Prichard, R.W. 1978: The need for new animal models-a philosphic approach Journal of the American Veterinary Medical Association 173(9): 1208-1209